flucytosine has been researched along with Fibrosarcoma in 2 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
Fibrosarcoma: A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simpson, GR | 1 |
| Han, Z | 1 |
| Liu, B | 1 |
| Wang, Y | 1 |
| Campbell, G | 1 |
| Coffin, RS | 1 |
| Dachs, GU | 1 |
| Patterson, AV | 1 |
| Firth, JD | 1 |
| Ratcliffe, PJ | 1 |
| Townsend, KM | 1 |
| Stratford, IJ | 1 |
| Harris, AL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase 1B Study of Intralesional Injection of RP1 in Patients With Resectable Cutaneous SCC[NCT05858229] | Phase 1/Phase 2 | 12 participants (Anticipated) | Interventional | 2023-06-16 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for flucytosine and Fibrosarcoma
| Article | Year |
|---|---|
Combination of a fusogenic glycoprotein, prodrug activation, and oncolytic herpes simplex virus for enhanced local tumor control.
Topics: Animals; Biotransformation; Cell Fusion; Combined Modality Therapy; Cytosine Deaminase; Fibrosarcoma | 2006 |
Targeting gene expression to hypoxic tumor cells.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Hypoxia; Cytosine Deaminase; DNA-Binding Proteins; Fi | 1997 |